Your Messages Inbox
Your Article Summary
See Latest ArticlesBayer Material Science lifts force majeure for TDI in Europe
BayNews International, 07/17/09
With immediate effect, Bayer MaterialScience has lifted force majeure for the polyurethane raw material toluene diisocyanate (TDI) in the Europe, Middle East, Africa (EMEA) region. The damage to the company’s chlorine electrolysis plant at the Brunsbüttel site has been repaired. The TDI facility with its total production capacity of 125,000 tons per year has thus returned to normal production.
Related Articles
Chinese Vice President Xi Jinping visits Bayer
BayNews International, 10/15/09
Relevance Score: 91%
Environmental Envoys from 19 countries visit Bayer: Project part of partnership between the United Nations Environment Programme and Bayer
BayNews International, 11/11/09
Relevance Score: 89%
Bayer MaterialScience relies on the labeling system of Bayer Technology Services worldwide
BayNews International, 10/15/09
Relevance Score: 89%
KINAXO Biotechnologies and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification
b3c newswire, 10/16/09
Relevance Score: 87%
Bayer Schering Pharma collaborates with AC Immune in the field of Alzheimer's disease
BayNews International, 10/15/09
Relevance Score: 87%
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Advisory Committee briefing materials for CRESTOR sNDA available on US FDA web site
AstraZeneca, 12/15/09
Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09
Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
GSK study showed targeted therapy combination achieved 14 month overall survival in patients with advanced breast cancer
GlaxoSmithKline, 12/15/09
New Phase II Study Showed Trastuzumab-DM1 Shrank Tumors in Women With Highly Advanced HER2-positive Breast Cancer
Genentech, 12/15/09
GSK and Intercell form strategic alliance to develop and commercialise innovative needle-free patch-based vaccines
GlaxoSmithKline, 12/15/09
Article Search
Sponsor